ONCOLOGY: December 2010 Supplement
Exploring the Clinical Decisions of US Community-Based Oncologists and Hematologists in the Management of Multiple Myeloma and Follicular LymphomaSupported by educational grants from Celgene Corporation, Cephalon Inc, and Millennium Pharmaceuticals Inc
Exploring the Clinical Decisions of US Community-Based Oncologists and Hematologists in the Management of Multiple Myeloma and Follicular Lymphoma
Supported by educational grants from Celgene Corporation, Cephalon Inc, and Millennium Pharmaceuticals Inc
To obtain a better understanding of community-based medical oncology practice patterns, 43 oncologists within the United States were recruited to complete a traditional clinical case–based questionnaire and to contribute specific anonymous demographic and treatment information derived from their actual patients. This information was used to create a cross-sectional case database on two types of cancer in which major clinical advances have been reported in recent years - multiple myeloma and follicular lymphoma.
To view the complete contents of the supplement, click on the titles of the three articles listed below.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
!["[These] data provide framework to assist in patient counseling and optimizing selection," according to the study authors.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2Fafc4e7af61f986692735b0d673f3933a45f75fc2-2249x2250.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "\"[These] data provide framework to assist in patient counseling and optimizing selection,\" according to the study authors.")
